Table of Content - Fibromyalgia Treatment Market

Global fibromyalgia treatment market is estimated to be valued at USD 3.07 BN in 2024 and is expected to exhibit a CAGR of 3.3% during the forecast period (2024-2031). Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.

Market Dynamics:

The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.

Key Features of the Study:

This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global fibromyalgia treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.

Market Segmentation

Drug Class:
- Antidepressants
- Antiepileptics
- Muscle Relaxants
- Analgesics
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Eli Lilly and Company
- Pfizer Inc.
- Novartis AG
- Allergan plc
- Sun Pharmaceutical Industries Ltd.
- Aptinyx Inc.
- Prismic Pharmaceuticals Inc.
- Innovative Med Concepts Inc.
- Intec Pharma Ltd.
- Astellas Pharma Inc.
- Johnson & Johnson
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Patent Litigations
- Reimbursement
- Patent Landscape (ANDA/NDA Intelligence)
- PEST Analysis
- Porter’s Analysis
Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Fibromyalgia Treatment Market, By Drug Class, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Antidepressants
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  - Segment Trends
- Antiepileptics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  - Segment Trends
- Muscle Relaxants
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Analgesics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Fibromyalgia Treatment Market, By Distribution Channel, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Fibromyalgia Treatment Market, By Region, 2019 – 2031, (USD BN)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Regions, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Company Profiles
  - Eli Lilly and Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Allergan plc
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Aptinyx, Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Prismic Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Innovative Med Concepts, Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Intec Pharma Ltd
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Astellas Pharma Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - GSK
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - AstraZeneca plc
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Bristol Myers Squibb
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Viatris
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Amgen Inc.
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Overview
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 35 figures on "Global Fibromyalgia Treatment Market” - forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount